Minnesota’s Prescription Drug Affordability Board was established to conduct cost reviews of prescription drug products and set payment limits.

The Prescription Drug Affordability Board is comprised of seven voting members appointed by the governor, one nonvoting member appointed by the majority leader of the senate; and one nonvoting member appointed by the speaker of the house.

Enabling legislation: 62J.87; Minnesota 2023 Laws, Chapter 57, Article 2, Section 30

Comments may be submitted to the Prescription Drug Affordability Board here: PDAB_Public_Comments

Contact Vernon Rowen, our Executive Director, at vernon.rowen@state.mn.us.

Public Meetings

Upcoming Meetings

PDAB Governance Work Session
August 10, 2026
9:00am to Noon
The Wilder Center
Auditorium A
451 Lexington Pkwy N
St. Paul, MN 55104

The Wilder Foundation (Google Maps)

Meeting Agenda TBD

Microsoft Teams meeting

Meeting ID: 283 482 723 681 382
Passcode: 6jv7Vc7J

________________________________________

Need help? | System reference
Dial in by phone
+1 651-395-7448, 376948642# United States, Minneapolis
Find a local number
Phone conference ID: 376 948 642#
Join on a video conferencing device
Tenant key: mn@m.webex.com
Video ID: 112 979 854 6

Past Meetings

July 31, 2026

• Agenda for July 31, 2026 (PDF)
• Video for July 31, 2026 (YouTube)
• PDAB Data Project Presentation (PDF)
• Minnesota PDAB Executive Director's Report (PDF)

July 2, 2026

• Agenda for July 2, 2026 (PDF)
• Video for July 2, 2026 (YouTube)
• PDAB Data Project Presentation July 2, 2026 (PDF)
• Minnesota PDAB Executive Director's Report July 2, 2026 (PDF)
• PDAAC Survey on Drug Selection Criteria and Data Sources for the MN PDAB (PDF)
• Overview of MN APCD & other MDH Rx Data Resources (PDF)
• Minutes for July 2, 2026 (PDF)

May 12, 2026

• Agenda for May 12, 2026 [pdf]
• Video for May 12, 2026 [YouTube]
• Cigna Group Presentation: Reinventing Prescription Benefits [pdf]
• Prime Therapeutics Presentation [pdf]
• PCMA Presentation:Understanding Pharmacy Benefit Managers & Prescriptions Drug Affordability [pdf]
• Commerce Presentation: Identifying Potential Drug Products for Cost Reviews [pdf]

April 14, 2026

• Agenda for April 14, 2026 meeting [pdf]
• Understanding Patient Perspectives on Prescriptions Drug Affordability [pdf]
• Maryland’s Prescription Drug Affordability Board: Progress & Upcoming Work [pdf]
• Prescription Drug Affordability Board Drug Selection & Cost Review Process [pdf]
• Video for April 14, 2026 meeting [mp4]
• Minutes for April 14, 2026 [pdf]

March 10, 2026

• Agenda for March 10, 2026 meeting [pdf]
• Prescription Medicines Costs in Context [pdf]
• Presentation - Medical Alley [pdf]
• Video for March 10, 2026 meeting [mp4]
• Minutes for March 10, 2026 [pdf]
• Annual Report Minnesota’s Prescription Drug Affordability Board [pdf]

February 10, 2026

• Agenda for February 10, 2026 meeting [pdf]
• Drug Lists for Review by the PDAB [pdf]
• PDAB Governance Process [pdf]
• PDAB Work Plan [pdf]
• The Role and Value of Pharmacy Services Administrative Organizations [pdf]
• Medicaid Pharmacy Overview [pdf]
• Healthcare Distribution Alliance [pdf]
• Video for February 10, 2026 meeting [mp4]
• Minutes for February 10, 2026 meeting [pdf]

January 13, 2026

• Agenda for January 13, 2026 board meeting (.pdf)
• Minutes for January 13, 2026 board meeting (.pdf)
• PDAB Governance Process (.pdf)
• PDAB Work Plan (.xlsx)
• PDAB presentation (.pdf)
• Video for January 13, 2026 meeting (.mp4)

December 9, 2025

• Agenda for December 9, 2025 board meeting (.pdf)
• PDAAC Affordability Survey Report (.pdf)
• Video for December 9, 2025 meeting (.mp4)
• PDAB Board to Executive Director Delegation policies draft (.pdf)
• Minutes for December 9, 2025 board meeting (.pdf)

November 19, 2025
Virtual Patient Listening Session

November 18, 2025

• Agenda for November 18, 2025 Board Meeting (.pdf)
• Draft of Governing Board to Executive Director Delegation (.pdf)
• Governance Timeline (.pdf)
• Data Practices Presentations (.pdf)
• Video for November 18, 2025 meeting (.mp4)
• Minutes for November 18, 2025 meeting (.pdf)

October 30, 2025

• October 30, Patient Listening Session (.pdf)

October 14, 2025

• Board Agenda for October 14, 2025 meeting (.pdf)
• Survey of Prescription Drug Rate Collection and Review Processes (.pdf)
• Draft PDAB Work Plan (.pdf)
• Video for October 14 meeting (.mp4)
• Minutes for October 14, 2025 meeting (.pdf)

September 9, 2025

• Board Agenda for September 9, 2025 meeting (.pdf)
• Minutes for September 9, 2025 meeting (.pdf)
• Draft of Mission and Vision Statement for September 9 meeting (.pdf)
• Executive Director's Report for September 9 meeting (.pdf)
• Private Health Insurance Market Impacts (.pdf)
• Final Mission Vision Values statement (.pdf)
• Meeting minutes for August 12 meeting (.pdf)
• Video for September 9 meeting (.mp4)

August 12, 2025 ?

• Board Agenda for August 12, 2025 meeting (.pdf)
• Draft Proprietary Information Policy - clean version (.pdf)
• Draft Proprietary Information Policy - redline version (.pdf)
• Memo Regarding Proprietary Information Policy Revisions (.pdf)
• Presentation: Achieving Prescription Drug Affordability (.pdf)
• Draft Proprietary and Trade Secret Information; Confidentiality Policy (July 2025) (.pdf)
• Executive Report for August 12, 2025 (.pdf)
• Draft Proprietary and Trade Secret Information with adopted edits from August 12, 2025 board meeting (.pdf)

Tuesday, July 8, 2025

• Board agenda for July 8, 2025 meeting (.pdf)
• Meeting minutes for July 8 2025 meeting (.pdf)
• Draft conflict of interest - clean version (.pdf)
• Draft conflict of interest  - redline version (.pdf)
• Draft proprietary information - clean version (.pdf)
• Draft proprietary information - redline version (.pdf)
• Federal Update on Prescription Drug Policy (.pdf)

June 10, 2025

• Board agenda for June 10, 2025 meeting (.pdf)
• Proposed revisions to bylaws (.pdf)
• Presentation on 340B Program and Considerations for PDABs (.pdf)

May 13, 2025

• Meeting agenda for May 13, 2025 meeting (.pdf)
• Meeting minutes for May 13, 2025 meeting (.pdf)
• Conflicts of Interest and Proprietary and Trade Secret Information Policies (.pdf)
• Introduction to MDH Technical Assistance (pdf)

April 15, 2025

• Meeting agenda (.pdf)
• PDAB Executive Director candidate score sheet (.pdf)
• CV for PDAB candidate Vernon Rowen CV (.pdf)
• CV for PDAB candidate Sarah Kae Derr (.pdf)
• Questions for Executive Director Candidates (.pdf)
• Interview presentation by Sarah Kae Kerr (.pdf)
• Interview presentation by Vernon Rowen (.pdf)

December 13, 2024

• PDAB_Meeting_Agenda_12_13_2024 [pdf]
• ED_Candidate_Resume_Caldwell_Alex [pdf]
• ED_Candidate_Resume_Sellner_John [pdf]
• ED_Candidate_Resume_Winter_Kate [pdf]
• ED_Candidate_Score_Sheet [pdf]

November 26, 2024

• Agenda for November 26 meeting [pdf]
• Minutes for November 26 meeting [pdf]
• ED_Candidate_Interview_Domains_and_Weights [pdf]
• PDAB_Staff_Hiring_Updates_11_26_2024 [pdf]
• PDAB_Staff_Hiring_Updates_Slide_4_Corrected_11_26_2024 [pdf]

July 23, 2024

• Agenda for July 23 meeting [pdf]
• PORTAL_Presentation [pdf]
• Prescription Drug Price Transparency [pdf]
• Structure of the Prescription Drug Market & Drug Prices [pdf]

June 20, 2024

• Agenda for June 20 Meeting [pdf]
• Minutes for June 20 Meeting [pdf]
• Draft of COI for Discussion 6-20-24 [pdf]
• COI Policy Presentation [pdf]
• Proprietary Information Presentation [pdf]
• Proprietary Information Packet [pdf]
• Statutory Price Transparency Overview [pdf]
• Prescription Drug Market Structure Presentation [pdf]

May 30, 2024

• Meeting agenda 5-30-2024 [pdf]
• Meeting Minutes 5-30-24 [pdf]
• Draft Bylaws of the PDAB [pdf]
• MDH RX Price Transparency Presentation [pdf]

May 22, 2024

• PDAB ED Responsibilities (.pdf)
• Meeting minutes 5-22-24 (.pdf)

April 30, 2024

• Updated_Meeting Agenda 4-30-24 [pdf]
• Draft PDAB Bylaws [pdf]
• PDAB Statutory Authority [pdf]
• Draft PDAB Executive Director Job Description [pdf]
• PDAB Staff Hiring Slides [pdf]
• Meeting minutes 4-30-24 [pdf]

March 26, 2024

• Meeting agenda_3-26-2024 [pdf]
• Meeting slides 3-26-2024 [pdf]
• Meeting minutes_3-26-2024 [pdf]